Brazilian lawmakers suffer from doubling clinical budget

As Brazil emerges from one of the world’s largest COVID-19 epidemics, after the United States, a coalition of educational and business teams is fighting for more investment for studies and trade innovation in the country.Brazil’s central budget for science and innovation until 2020 was approved by the Senate on 13 August with an almost unanimous vote, but before victory can be declared, the proposal will have to transparent the declining space of the country’s National Congress and a possible confrontation.with President Jair Bolsonaro, who has called for drastic cuts in clinical budgets since it came into force last year and may simply veto the law.

Scientific companies, adding the Brazilian Academy of Sciences, and industry and industry teams have come together in combination to help legislation, which would lose coins from a special fund for commercial innovation and other research.They argue that years of budget cuts to science have made it difficult to respond to the COVID-19 crisis in Brazil and that increased investment may be just efforts to better understand, diagnose and treat the disease. Adjusted for inflation, investment for Brazil’s primary clinical budget has risen from a peak of approximately R$14 billion (about US$2.55 billion) in 2014 – just before a crippling two-year economic recession – to about R$4.4 billion in 2020.Add 4.6 billion reais to Brazil’s clinical accounts and, more importantly, ensure a permanent source of coins for the protected.management science and the future of Bolsonaro.

Responding to the August 13 vote, Luiz Davidovich, the theoretical physicist of the Federal University of Rio de Janeiro and president of the Brazilian Academy of Sciences, said: “What happened in the Senate is incredible.This would generate investments for studies in all sectors of society.

If successful, the cash will come from the Brazilian National Fund for the Development of Science and Technology (FNDCT), a key clinical account that is automatically financed through taxes collected from corporations and industries, adding biotechnology and energy corporations.In addition to broader studies and progression activities, the fund has earned several billion reais over more than 4 years; however, the maximum of that cash was with retained under a 2000 law that allows the government to divert those budgets to pay off the national debt.In 2020, the fund received 5.2 billion reais, but The Bolsonaro administration chose to retain scientists for more than 88% of the total.

The bill would be contrary to that resolution and would create a scientific fund that the executive branch cannot divert in the future.It would require that all unspent budgets at the end of the year be held within next year.As a rule, unspent cash from the fund is returned to the Brazilian Treasury.

For some scientists, the Senate’s overwhelming vote is a popularity of the role doctors, scientists and the biotech industry have played when COVID-19 swept through Brazil, where the disease has so far inflamed more than 3.3 million people and killed some 109,000.In particular, the government’s investments in commercial studies and progression have paid off, as Brazilian corporations have intervened to build enthusiasts and medical devices to combat COVID-19, said Carlos Henrique de Brito Cruz, a physicist at The State University of Campinas, who in the past led the Sao Paulo Research Foundation, a clinical investment firm in the country’s most populous state.

“The pandemic has made public that science is needed,” Cruz says.

But the legislation, if passed in its current form, may leave some scientists behind. So far, 25% of the total national budget has been spent on loans to industry for innovation projects, but the proposal would allow this figure to increase up to 50% .This may mean less money than planned for scholarships for university studies popular and related scholarships for academics and postdocs, which have been threatened by Bolsonaro.

In March 2019, just a few months after taking office, Bolsonaro sought to freeze the Ministry of Science and Technology’s investment, a resolution that would have cut scholarships for thousands of undergraduate and graduate academics, as well as postdoctoral researchers., however, scientists remain involved in their monetary security.

Davidovich says the next vote on the law may take a position in the coming weeks.If it passes in the lower house, Brazil’s Congress would have more than enough votes to override a possible Bolsonaro veto.

Unfortunately, the law will resolve the monetary and political unrest faced by Brazilian science, says Sergio Rezende, former science and physicist minister at the Federal University of Pernambuco in Recife, Brazil.”With the existing federal government, science in Brazil will continue.under-support.”

News 28 AO 20

Editorial 26 AO 20

Comment 25 AO 20

Q News

Correspondence August 19, 20

Q News

Comment 02 SEP 20

Editorial 01 SEP 20

Chronic career 26 AO 20

Leave a Comment

Your email address will not be published. Required fields are marked *